Tanzania Neurology Clinical Trials Market Report 2022 to 2030

Tanzania Neurology Clinical Trials Market Analysis

$ 3999

The Tanzania Neurology Clinical Trials market is projected to grow from $2.09 Mn in 2022 to $3.44 Mn by 2030, registering a CAGR of 6.4% during the forecast period of 2022 - 2030. The market will be driven by investment in infrastructure, resources, and training for healthcare professionals, as well as collaboration between local and international stakeholders. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Sanofi S.A., AstraZeneca & GlaxoSmithKline.

ID: IN10TZCT005 CATEGORY: Clinical Trials GEOGRAPHY: Tanzania AUTHOR: Vidhi Upadhyay

Buy Now

Tanzania Neurology Clinical Trials Market Executive Summary

The Tanzania Neurology Clinical Trials market is projected to grow from $2.09 Mn in 2022 to $3.44 Mn by 2030, registering a CAGR of 6.4% during the forecast period of 2022 - 2030. Tanzania's population also has among the world's lowest rates of access to health personnel. Approximately 60% of Tanzania's healthcare facilities are government-run, with the remainder being faith-based or private. As Tanzania advances towards universal healthcare, the government allotted $387.9 million for the health sector in 2020/2021, of which $155.5 million would be spent on development projects to assist the government in implementing its health-improving efforts. According to the World Health Organization (WHO), neurological illnesses account for around 10% of the country's overall disease burden. Tanzania performed one of the few known population-based stroke incidence studies from SSA and discovered an age-standardized incidence rate of up to 316 per 100,000 people.

Clinical trials are an essential part of medical research since they are used to evaluate the safety and efficacy of new drugs, medical equipment, or treatments. Clinical trials are conducted to determine that innovative therapies or drugs are safe, effective, and appropriate for use in patient care. Neurology clinical trials, in particular, focus on treatments for neurological ailments such as Alzheimer's disease, multiple sclerosis, Parkinson's disease, stroke, and others. In Tanzania, neurology clinical trials are still very restricted in comparison to other countries, and the number of active studies in this sector is minimal. In recent years, however, there has been some success, with a few clinical trials in Tanzania evaluating novel treatments and therapies for neurological illnesses. There are several hospitals supportive of clinical trials such as Muhimbili National Hospital, Kilimanjaro Christian Medical Centre, Ifakara Health Institute, Bugando Medical Centre and others.

Tanzania Neurology Clinical Trials Market

Market Dynamics

Market Growth Drivers

The high prevalence of neurological illnesses in Tanzania, including epilepsy, stroke, and neuro-infections, is one of the key drivers of growth. This has resulted in an urgent need for novel treatments and therapies, as well as improved access to current ones. Another driver of expansion is the growing interest in doing clinical research in Tanzania from both local and international partners. Tanzania has been recognised as a viable place for undertaking this sort of study due to a rising realisation of the need to create novel treatments and therapies that are especially suited to the requirements of patients in low-resource settings.

Market Restraints

There are also various constraints impeding the expansion of neurology clinical trials in Tanzania. One of the most significant problems is the country's poor infrastructure and resources for performing clinical research, especially in rural regions. This has resulted in a concentration of clinical studies in cities, which may restrict the generalizability of the findings to the general population. Another challenge is a lack of skilled healthcare personnel, notably neurologists and other experts required to conduct and monitor clinical studies. As a result, there is a greater dependence on overseas partners, which might provide extra obstacles in terms of coordination, communication, and cultural differences.

Competitive Landscape

Key Players

Novartis AG
Eli Lilly and Company
Roche Holding AG
Sanofi S.A.
AstraZeneca
GlaxoSmithKline (GSK)

Healthcare Policies and Regulatory Landscape

The Tanzania Medicines and Medical Devices Authority (TMDA) and the Tanzania Commission for Science and Technology govern and supervise clinical research in Tanzania (COSTECH). In Tanzania, the TMDA is the regulatory body in charge of clinical trial authorization, monitoring, and inspections. In line with the TMMDAct and the CT-Regs, the TMDA gives approval for clinical trials to be undertaken in the nation.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Neurology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

Phase I
Phase II
Phase III
Phase IV

By Study Design Outlook (Revenue, USD Billion):

Epilepsy
Parkinson's Disease (PD)
Huntington's Disease
Stroke
Traumatic Brain Injury (TBI)
Amyotrophic Lateral Sclerosis (ALS)
Muscle regeneration
Others

By Indication Outlook (Revenue, USD Billion):

Interventional
Observational
Expanded Access

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.